Clinical Coverage/Medical Policy Updates
QualChoice updates a select number of clinical coverage policies each month, ensuring the reviewal of all policies on an annual basis.
CP.BH.500 - BH Treatment Documentation Requirements (PDF)
CP.MP.115 - Discography (PDF)
CP.MP.116 - Lysis of Epidural Lesions (PDF)
CP.MP.120 - Pediatric Liver Transplant (PDF)
CP.MP.147 - Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention (PDF)
CP.MP.175 - Air Ambulance (PDF)
CP.MP.188 - Pediatric Oral Function Therapy (PDF)
CP.MP.210 - Repair of Nasal Valve Compromise (PDF)
CP.MP.244 - Liposuction for Lipedema (PDF)
CP.MP.24 - Multiple Sleep Latency Testing (PDF)
CP.MP.58 - Intestinal and Multivisceral Transplant (PDF)
CP.MP.87 - Therapeutic Utilization of Inhaled Nitric Oxide (PDF)
CP.MP.91 - Obstetrical Home Care Programs (PDF)
CP.MP.91 - OB Home Programs (PDF)
CP.MP.40 - Gastric Electrical Stimulation (PDF)
CP.MP.132 - Heart-Lung Transplant (PDF)
CP.MP.141 - Non-Myeloablative Allogeneic Stem Cell Transplants (PDF)
CP.MP.115 - Discography (PDF)
CP.MP.116 - Lysis of Epidural Lesions (PDF)
CP.MP.120 - Pediatric Liver Transplant (PDF)
CP.MP.147 - Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention (PDF)
CP.MP.175 - Air Ambulance (PDF)
CP.MP.188 - Pediatric Oral Function Therapy (PDF)
CP.MP.210 - Repair of Nasal Valve Compromise (PDF)
CP.MP.244 - Liposuction for Lipedema (PDF)
CP.MP.24 - Multiple Sleep Latency Testing (PDF)
CP.MP.58 - Intestinal and Multivisceral Transplant (PDF)
CP.MP.87 - Therapeutic Utilization of Inhaled Nitric Oxide (PDF)
CP.MP.91 - Obstetrical Home Care Programs (PDF)
CP.MP.91 - OB Home Programs (PDF)
CP.MP.40 - Gastric Electrical Stimulation (PDF)
CP.MP.132 - Heart-Lung Transplant (PDF)
CP.MP.141 - Non-Myeloablative Allogeneic Stem Cell Transplants (PDF)
CP.MP.146 - Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins (PDF)
CP.MP.69 - Intensity-Modulated Radiotherapy (PDF)
V2.2024 - CG Aortopathies Connective Tissue (PDF)
V2.2024 - CG Cardiac Disorders (PDF)
V2.2024 - CG Dermatologic Conditions (PDF)
V2.2024 - CG Epilepsy Neurodegenerative and Neuromuscular Disorders (PDF)
V2.2024 - CG Exome Genome Sequencing (PDF)
V2.2024 - CG Eye Disorders (PDF)
V2.2024 - CG General Approach to Genetic and Molecular Testing (PDF)
V2.2024 - CG Hearing Loss (PDF)
V2.2024 - CG Hematologic Conditions Non-Cancerous (PDF)
V2.2024 - CG Hereditary Cancer Susceptibility (PDF)
V2.2024 - CG Immune, Autoimmune, and Rheumatoid Disorders (PDF)
V2.2024 - CG Kidney Disorders (PDF)
V2.2024 - CG Lung Disorders (PDF)
V2.2024 - CG Metabolic, Endocrine and Mitochondrial Disorders (PDF)
V2.2024 - CG Multisystem Inherited Disorders, ID and Developmental Delay (PDF)
V2.2024 - CG Non-invasive Prenatal Screening (PDF)
V2.2024 - CG Oncology Algorithmic Testing (PDF)
V2.2024 - CG Oncology Cancer Screening (PDF)
V2.2024 - CG Oncology Circulating Tumor DNA Tumor Cells Liquid Biopsy (PDF)
V2.2024 - CG Oncology Cytogenetic Testing (PDF)
V2.2024 - CG Oncology Molecular Analysis of Solid Tumor and Hem Malignancies (PDF)
V2.2024 - CG Pharmacogenetics (PDF)
V2.2024 - CG Preimplantation Genetic Testing (PDF)
V2.2024 - CG Prenatal and Preconception Carrier Screening (PDF)
V2.2024 - CG Prenatal Diagnosis of Amnio CVS or PUBS and Pregnancy Loss (PDF)
V2.2024 - CG Skeletal Dysplasia and Rare Bone Disorders (PDF)
V2.2024 - CG Gastroenterologic Disorders Non-Cancerous (PDF)
CP.MP.69 - Intensity-Modulated Radiotherapy (PDF)
V2.2024 - CG Aortopathies Connective Tissue (PDF)
V2.2024 - CG Cardiac Disorders (PDF)
V2.2024 - CG Dermatologic Conditions (PDF)
V2.2024 - CG Epilepsy Neurodegenerative and Neuromuscular Disorders (PDF)
V2.2024 - CG Exome Genome Sequencing (PDF)
V2.2024 - CG Eye Disorders (PDF)
V2.2024 - CG General Approach to Genetic and Molecular Testing (PDF)
V2.2024 - CG Hearing Loss (PDF)
V2.2024 - CG Hematologic Conditions Non-Cancerous (PDF)
V2.2024 - CG Hereditary Cancer Susceptibility (PDF)
V2.2024 - CG Immune, Autoimmune, and Rheumatoid Disorders (PDF)
V2.2024 - CG Kidney Disorders (PDF)
V2.2024 - CG Lung Disorders (PDF)
V2.2024 - CG Metabolic, Endocrine and Mitochondrial Disorders (PDF)
V2.2024 - CG Multisystem Inherited Disorders, ID and Developmental Delay (PDF)
V2.2024 - CG Non-invasive Prenatal Screening (PDF)
V2.2024 - CG Oncology Algorithmic Testing (PDF)
V2.2024 - CG Oncology Cancer Screening (PDF)
V2.2024 - CG Oncology Circulating Tumor DNA Tumor Cells Liquid Biopsy (PDF)
V2.2024 - CG Oncology Cytogenetic Testing (PDF)
V2.2024 - CG Oncology Molecular Analysis of Solid Tumor and Hem Malignancies (PDF)
V2.2024 - CG Pharmacogenetics (PDF)
V2.2024 - CG Preimplantation Genetic Testing (PDF)
V2.2024 - CG Prenatal and Preconception Carrier Screening (PDF)
V2.2024 - CG Prenatal Diagnosis of Amnio CVS or PUBS and Pregnancy Loss (PDF)
V2.2024 - CG Skeletal Dysplasia and Rare Bone Disorders (PDF)
V2.2024 - CG Gastroenterologic Disorders Non-Cancerous (PDF)
CP.MP.107 - Durable Medical Equipment and Orthotics and Prosthetics Guidelines (PDF)
CP.MP.114 - Disc Decompresion Procedures (PDF)
CP.MP.117 - Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (PDF)
CP.MP.126 - Sacroiliac Joint Fusion (PDF)
CP.MP.184 - Home Ventilators (PDF)
CP.MP.114 - Disc Decompresion Procedures (PDF)
CP.MP.117 - Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (PDF)
CP.MP.126 - Sacroiliac Joint Fusion (PDF)
CP.MP.184 - Home Ventilators (PDF)